In Search of Memory – BONUS POST

The Bonus Book of the Week is “In Search of Memory” by Eric R. Kandel, published in 2006. This book was mostly about neurology and psychoanalysis. The autobiographical parts included descriptions of how and why the author’s family fled Austria for the United States in 1939, and his role in reconciling psychology and biology.

Kandel identified himself as Jewish. He explained that “racial anti-Semitism” is the idea perpetrated by the Catholic Church that the Jews killed Christ and therefore, they are members of “… a race so innately lacking in humanity that they must be genetically different, subhuman.” Such idea was used to justify genocide during the Spanish Inquisition and of course, the Holocaust. Gentiles in Germany, Poland and Austria especially, took up the cudgel of racial anti-Semitism during the Holocaust.

However, what is interesting is, that while the Catholic Church calls the Jews a “race” as a putdown, the Jews think of it as a point of pride.

When American Jews use the term”born Jewish” ironically, most are unaware of the belief that Jews as a group are thought by anti-Semites to have genes in common that bring out their stereotyped, negative traits. By born Jewish, they mean to say, they, like religious Jews, believe that Jews are automatically Jews regardless of their beliefs or observances, because their mothers were Jewish. Not in a derogatory way.

But wait. If people can convert to or from Judaism, it’s not genetic. Hindu people could actually call themselves a “race” because they allow no conversions. That’s the difference. The Hindus were a group of people who did all share the same genes up until the time they started marrying non-Hindus and having children.

By the way, read the book to learn about the progression of the fields of neurology and psychology in the twentieth century.

The World According to Monsanto – URGENT POST

The Book of the Decade is  “The World According to Monsanto– Pollution, Corruption, and the Control of Our Food Supply” by Marie-Monique Robin, published in 2010.

The author wrote, “When one dissects Monsanto’s activity reports (contained in 10-K forms [annual reports filed with the Securities and Exchange Commission in the United States]) since 1997, one is struck by the place taken up by litigation.”

There are no companies that can fairly be compared to Monsanto in terms of payments to victims for irreparable harm, permanent injury and wrongful deaths caused by the environmental damage done by Monsanto. They couldn’t possibly compete. But the following is a summary of recent expenses of the legal bullying of, and financial punishments handed down, to Monsanto.

Monsanto’s 2017 annual report’s footnotes showed $33 million in expenses associated with “environmental and litigation matters.” The company’s 2015 Restructuring Plan included $167 million of the same kinds of aforementioned expenses and “a SEC settlement.” The cost of goods sold was $101 million. That means, its litigation expenses exceeded the costs of producing its products. Besides, annual reports don’t normally contain the exact phrase “environmental and litigation matters.”

Another item included $32 million of expenses related to “legacy environmental settlements.” Monsanto recorded the settlement of its polychlorinated biphenyls (PCBs) legal troubles for $280 million in fiscal 2016. Lastly (finally!), the “Long-Term Portion of Environmental and Litigation Liabilities” accounts for almost 1 1/2% of the company’s “Total Liabilities” for the year.

What makes Monsanto’s excessive litigation egregious is that it has so much worldwide hegemony that it wins its cases most of the time– the company itself sues everyone who gets in the way of its profit-making, and successfully defends itself against the countless plaintiffs who have legitimate causes of action against it.

Not to mention the fact that it had basically formed a public-private partnership (largely via political contributions and lobbying), with the American government as of the book’s writing. That is why whistleblowers and activists get crushed in its wake.

Sounds familiar… Unfortunately, the reason history repeats itself so often is that human nature doesn’t change. What makes Monsanto’s case so much scarier than the situations with other, similar monstrous entities is that Monsanto has the potential to permanently contaminate nearly the entire world’s food supply, and there have already been significant consequences of that nature due to its unbridled greed. Yes, it is that bad.

Founded as a chemical and plastics company in 1901 in Saint Louis, Missouri– Monsanto went public in 1929. It made DDT, dioxin, aspartame, (and inadvertently but knowingly and ruthlessly, PCBs), among other substances that have done permanent harm to a large number of people.

As of this book’s writing, Monsanto had a presence in 46 nations and owned 90% of the patents for all Genetically Modified Organisms internationally grown. It makes billions of dollars in profit annually.

The author traveled extensively to interview numerous people to gather a voluminous amount of data on Monsanto’s quest to make the maximum amount of money it possibly can, at the expense of humanity. The scientists she interviewed– including friends and foes of Monsanto– all said they wouldn’t eat the genetically modified foods borne of Monsanto products.

The author tells lots of anecdotes about people from all different geographic areas who have been adversely affected by the chemicals and genetically modified organisms sold by Monsanto, plus about several people previously affiliated with the company and U.S. government agencies, who were clearly still loyal to their former employers. One such interviewee displayed the body language of a liar: excessive blinking when answering her pressing questions. She also pored over declassified documents that indicate outrageous corporate wrongdoing.

Monsanto’s employees currently research, apply for patents to, and sell genetically modified seeds for growing soybeans, corn, cotton and rapeseed; plus a herbicide– Roundup, an insecticide– Bt toxin, and the bovine growth hormone rBST.

The author wrote that in 1983, the American federal government set aside funds called the Superfund Program to decontaminate toxic waste sites around the nation. When some of those funds were diverted to “… finance the electoral campaigns of Republican candidates, Congress discovered that documents that would compromise the companies[,] disappeared.”

As might be recalled, the Reagan administration had a reputation for being staunchly pro-business; so much so that it made EPA worker Anne Burford and her colleague Rita Lavelle the scapegoats of a scandal after pressuring them to shred documents (which would have implicated Monsanto) and commit other crimes in connection with the town of Times Beach, Missouri– a dioxin-and-PCBs-contaminated site.

That contamination resulted in the deaths of numerous animals, serious health problems for the people there, and forced permanent evacuation of the eight-hundred family resort town.

The author spoke with several whistleblowers. All were punished by their employers. One from the EPA distributed an inflammatory memo saying Monsanto published false research results on its products. Another from the FDA wrote a report on the flaws in Monsanto’s application for approval of the artificial growth hormone rBST. He was fired in 1989, sued, and years later, won a job back at the FDA, but not one for which he was suited.

Monsanto’s rBST (still currently used at some dairy farms), when injected into cows, causes them to produce more milk (translation: more money). With the hormone, other substances are also likely to get into the milk, such as pus and antibiotics. This is because the injection sites on the cows form abscesses, necessitating the administering of antibiotics to the cows. Further, with rBST, the cows develop serious health problems, like ovarian cysts, mastitis and uterine disorders. Never mind humans who drink their milk.

In an unprecedented move, the FDA changed its own rules and approved rBST in November 1993 without forcing Monsanto to reply to its concerns and recommendations.

In the late 1980’s, a genetically modified dietary supplement sold by prescription only caused serious health problems, killing at least 37 and permanently disabling 1,500. If that kind of harm was done by a regulated item meant to be eaten that was genetically modified around the same time that Monsanto was testing rBST– a part of a product that millions of people would consume, shouldn’t the FDA have been more prudent in its approval process of rBST??

Monsanto sued the dairies that said on their milk-container labels that their milk contained no rBST. The defendants were forced to change their labeling.

In the late 1990’s, there was the TV-journalist-couple who were working on a show with negative coverage on Monsanto, when their employer was taken over by Fox News. They were fired because they refused to switch from telling the truth, to lying about Monsanto.

In 2003, after the couple suffered years of emotionally and bank-account draining litigation, “The [federal] judges considered that no law prohibited a television network or a newspaper company from lying to the public. To be sure, the rules established by the FCC prohibited it, but they did not have the force of law.” No wonder journalism is dead.

Conflicts of interest abounded in the 1990’s , when supposedly scholarly journal (peer-reviewed) articles (like Science, Nature and the Journal of the American Medical Association) declared that Monsanto’s products were safe; those articles were written by people paid by Monsanto.

Reputable scientists pointed out that Monsanto’s scientific testing involved non-standard procedures, and was statistically suspect as it was of too short a duration, and had too small a sample size.

Read the book to learn about:

  • horror stories resulting from Monsanto’s underhanded tactics regarding testing and use of its products, including the herbicide Roundup;
  • its victims in Anniston, Alabama who were subjected to PCBs;
  • which of Monsanto’s products was banned in 2000 in Canada and Europe;
  • how Monsanto is active in the United Nations;
  • how deregulation perpetuates Monsanto’s worldwide hegemony;
  • which ten or so individual American government officials acted on Monsanto’s behalf, but had undisclosed conflicts of interest [there was scant room in the book to list all those who were ethically challenged Monsanto affiliates— wait, that’s redundant];
  • the percentages of all foods genetically modified in specific categories in 2005;
  • how taxpayers footed the bill for Monsanto’s aggressive use of legal and political weaponry against American soybean farmers (whom it seriously harmed by taking away their livelihoods through duress and illegally spying on them in the late 1990’s) from 1999 into 2002;
  • why Monsanto dropped its initiative to introduce a transgenic wheat, even after spending hundreds of millions of dollars in connection therewith;
  • how Mexico has been harmed by Monsanto’s transgenic corn;
  • how Argentina and Paraguay have been harmed by Monsanto’s transgenic soybeans;
  • how India has been harmed by Monsanto’s transgenic cotton;
  • how Canadian farmers have been harmed by transgenic canola;
  • what transpired when, in January 2005, the Securities and Exchange Commission launched a legal proceeding against Monsanto for corruption in Indonesia;
  • why the World Trade Organization should share some blame for allowing the worldwide spread of Monsanto’s tentacles;
  • and much more.

Endnote:  Feel free to browse other posts for additional examples of entities behaving badly under the category “Business Ethics.”

Appetite for Self-Destruction

The Book of the Week is “Appetite for Self-Destruction, The Spectacular Crash of the Record Industry in the Digital Age” by Steve Knopper, published in 2009. This is an account of how the American music industry, for the most part, reacted badly to the jarring changes wrought by technological advances starting in the late 1970’s.

For decades prior to the 1970’s, the music market in the United States had had a shady reputation– involving drugs, kickbacks, bribes and cronyism, among other vices.

Even after CDs proved to provide sound that was superior to plastic records, entities in the music industry supply chain resisted making CDs because it necessitated the reconfiguring of their: factories, marketing materials, store displays, etc. Modernizing everything was expensive.

In 1978, the Sony CDP-101 could play the first CD title:  “52nd Street” from Billy Joel. But only in Japan. PolyGram Records, CBS Records and Sony understood the value of the new product. Arista Records, Capitol Records and EMI didn’t.

In addition to the widespread introduction of CDs in America by the late 1980’s, the sale of CBS Records was another disruptive force in the industry, resulting in power struggles and lots of layoffs. The old-school record labels depended on MTV, radio and music stores to distribute their wares for another decade.

The tail end of the 1990’s saw a new technology that really turned the industry on its ear:  the World Wide Web. It enabled people to create software that allowed free (no-cost and no restrictions) electronic-music-file sharing. In December 1999, the organization regulating intellectual property rights on music, the RIAA, sued one of the major organizations doing the sharing– Napster– for copyright violations. By the following summer, the latter had approximately nineteen million users per month.

Read the book to learn of the outcome of the above and other legal battles; the new 1990’s and early 2000’s music conduits and devices, their relationships to the laws on music piracy; and many other actions taken by the American music industry that have fueled the current state of digital music sales.

Wired

The Book of the Week is “Wired, The Short Life & Fast Times of John Belushi” by Bob Woodward, published in 1984. This is a career biography of the performer best known for his sketches on “Saturday Night Live” (SNL), “Animal House” and “The Blues Brothers.”

Born in 1949, Belushi started his career at an early age, thanks to a paternal high school drama teacher. Belushi formed a comedy troupe in college. At the youngest age ever (22), he  joined the improv group, “Second City” in Chicago.

Belushi’s brand of comedy was lowbrow and attention-whorish. He became the onstage focus when he joined such group-oriented acting companies as SNL and Second City; this irked his fellow performers.

Belushi met the younger and less experienced Chevy Chase when they performed in an Off-Broadway black comedy about death. Then came a National-Lampoon-produced radio show, and SNL.  Other roles included Bluto in the movie “Animal House” and comedian Dan Akroyd’s partner in the movie “The Blues Brothers.”

As is typical of talented yet insecure performers who hit the big-time almost immediately, behavior problems abound. But since the star is “the goose that laid the golden egg” his or her behavior is tolerated.

“… John could inflict remarkable chaos… There was no telling what was gone or broken or misused. It seemed that John had dipped his fingers into everything in the refrigerator” while attending a 1982 Super Bowl party at the home of his agent, Bernie Brillstein.

Toward the end of his life (which should not have been unforeseen), Belushi was surrounded by enablers to his cocaine addiction. He was provided weekly with $2,500 cash for “expenses” in a “don’t ask, don’t tell” policy with his business associates. They allowed him to act like a spoiled child borne of their own greed, or out of trying to avoid the hypocrisy of being drug addicts themselves. They continued to believe in his talent even though the movies he did after Animal House were money-losers.  A major rationalization of that era was that cocaine was unavoidable backstage at SNL and it was uncool to decline to socialize with one’s fellow comedians.

Read the book to learn the details of how Belushi ended up the way he did.

 

Brain Food

The Book of the Week is “Brain Food” by Dr. Brian Morgan and Roberta Morgan, published in 1987. This book discusses how diet can affect brain health, and which nutrients to consume in order to improve brain function when certain conditions are present. It covers stress, moods, appetite, PMS, learning and memory, allergies, drugs, brain development and aging.

In recent decades, there have been numerous contradictory studies sponsored by entities that wish to promote particular edibles. The authors of this book backed up their suggestions with credible scientific sources, and did not make any sensational claims about one specific substance or food.

Common sense dictates that exercise tailored to an individual is always healthy. An exercise program might call for additional protein consumption, however, as muscles require it for growth.

The brain is unable to store oxygen or energy, so it must consume a few hundred calories a day and receive a continuous blood supply. Calories that have particular nutrients, are going to optimize brain function. Here is some information on the kinds of nutrients to eat to maintain a healthy mind and body:

Vitamins B1, B6 and B12 are important for maintaining healthy neurological structure and activity. Whole grains are a source of the B vitamins.

Serotonin and dopamine are neurotransmitters that aid sleep and produce positive emotional vibes. Magnesium and vitamin B6 stimulate their production. B6 can be found in bananas, Grape Nuts, fish, liver and peanuts. Happily for some people, magnesium is found in chocolate; also– spinach and almonds.

The body is likely to be deficient in protein and calcium when it experiences stress of prolonged duration.

Studies have shown that a high-protein diet accelerates aging. Thus, protein should comprise only 13% of calories eaten. If taste buds become dulled with aging, try a zinc supplement.
Animal fat worsens artery clogging. One substance that might help is pectin, found in apples, oranges and grapefruit. Eating fish is also a mitigating factor.

High blood pressure increases with the consumption of pickled foods and cold cuts. It might decrease with potassium-filled citrus fruit, leafy greens, raisins and almonds.

According to the authors, the key to peak intellectual performance is sufficient iron– found in liver, Grape Nuts, beef, carrots, lamb and raisins. Memory can be improved with lecithin supplements. Don’t forget to eat wheat germ, peanuts and ham. Another important nutrient is vitamin E, found in leafy greens, other vegetables and whole grains.

Of course, all of the above should be done in moderation and the reader should consult his or her doctor before a radical diet is started. Read the book to learn a wealth of additional information on the substances to put in your body to stay happy and healthy.

High

The Book of the Week is “High” by Brian O’Dea, published in 2006. This book describes the adventures of an international drug-smuggling participant and addict between the 1970’s and the very early 1990’s.

O’Dea was the son of a brewery owner in Newfoundland, Canada. In the mid-1970’s, he and his smuggling partners secreted cocaine “… in false-bottomed suitcases at the factory in Bogota (Colombia) and muled to Kingston (Jamaica) via Lufthansa…” and unloaded the drug at Montego Bay. Other partners “… would be getting strapped up with the product on their thighs and stomachs and backs. Each person would carry between two and four kilos, worth between $100,000 and $200,000.”

Read the book to learn of the author’s Jamaica trials and tribulations with airplane mishaps, romantic subplots, prison and addiction experiences, his role in an elaborate three-continent marijuana distribution concern, and what finally became of him.

The Antidote

The Book of the Week is “The Antidote” by Barry Werth, published in 2014. This suspenseful saga is about the public drug company, Vertex.

Vertex has created the core substances in drugs that treat niche diseases, such as hepatitis C and cystic fibrosis. It has partnered with various other drug companies to use their resources.

Unconventionally, in the 1990’s, Vertex’s employees were organized into teams working on protein targets rather than those working on different diseases. The company’s teams were demoralized when they failed month after month to come up with a successful molecule.

The cost of American drugs is so high not just because the drugmakers are greedy, but because their employees feel entitled to a large reward for creating an effective product that does minimal harm to patients. They take tremendous risks– acquire pricey, extensive educations in organic chemistry and such, working long daily hours, suffer loads of stress from dealing with grant applications, patent disputes, licensing issues, doctor-insurer issues, undergoing the rigorous process of seeking FDA approval after laboring months or years on a drug substance– possibly applying for approval at the same time as another company with a competing product, and face the possibility of being laid off anytime. This is why life-saving, life-prolonging medicines are astronomically expensive. However, the drugs would not exist, but for the necessary evil of a greed machine that raises the funds to pay for the price of creating them.

Vertex posted a “profit” of more than $2 million in the fourth quarter of 1993, even though it had yet to sell even one pill. Its financial arrangements with its partners allowed it to claim that its income exceeded its expenses. By the end of the 1990’s, however, there were still no actual drugs produced, and the company was likely many years and hundreds of millions of dollars from the market. It was thus a likely takeover target. Some of Vertex’s scientists and lawyers became avid day-traders of the company’s stock in the autumn of 2000, after a deal with Novartis.

Trading rumors fly all the time, and one influential analyst at a big-name investment bank might downgrade a drug company’s stock, causing a selloff. In the early 2000’s, there was an SEC accusation of insider trading against Vertex’s house counsel. Ironically, it is common practice for panel members of the FDA to receive financial support in research-funding from many pharmaceutical companies.

Those companies that are public must answer to Wall Street. Unsurprisingly, at numerous medical conferences, their executives spout cliches such as “…We believe it’s a matter of time before we break this disease wide open and make a really big difference for a lot of people.”

Read the book to learn about actions Vertex took in research, development and finance in order to stay in business twenty years while accumulating losses of more than $1.5 billion; the causes of its high turnover of executives; how it became more geared toward finding commercial applications with its research results, and how it had fared product-wise and financially by autumn 2013.